GVI Oncology Outeniqua Unit

George 6530

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Studies at this site

• A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck — Stopped early
• Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer — Completed